Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
about
Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung CancerA Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-AnalysisRole of the XPA protein in the NER pathway: A perspective on the function of structural disorder in macromolecular assemblyPharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseGenetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis.XRCC1 genetic polymorphisms and sensitivity to platinum-based drugs in non-small cell lung cancer: an update meta-analysis based on 4708 subjectsPolymorphisms in ERCC1 and XPF gene and response to chemotherapy and overall survival of non-small cell lung cancer.Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients.Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer.Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy.Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis.Functional intronic ERCC1 polymorphism from regulomeDB can predict survival in lung cancer after surgeryRole of GSTP1 Ile105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms in the clinical outcome of advanced non-small cell lung cancerThe genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.Pharmacogenomics of platinum-based chemotherapy response in NSCLC: a genotyping study and a pooled analysisXPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.XPG genetic polymorphisms and clinical outcome of patients with advanced non-small cell lung cancer under platinum-based treatment: a meta-analysis of 12 studies.The association of genetic variations in DNA repair pathways with severe toxicities in NSCLC patients undergoing platinum-based chemotherapy.A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancer.Pharmacogenomics of platinum-based chemotherapy sensitivity in NSCLC: toward precision medicine.Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems.Effects of p38MAPK-mediated excision repair cross-complementation 1 expression on prognosis of patients with non-small cell lung cancer.Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer.Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis.Pharmacogenetic analysis of irreversible severe cisplatin-induced nephropathy: a case report of a 27-year-old woman.Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1.Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy.Chinese C allele carriers of the ERCC5 rs1047768 polymorphism are more sensitive to platinum-based chemotherapy: a meta-analysis.Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients.Screening of pharmacogenetic variants associated with drug sensitivity in patients with papillary thyroid carcinoma using next generation sequencingTruSight Cancer Sequencing Panel reveals pharmacogenetic variants associated with sensitivity to chemotherapy in lung cancer
P2860
Q26743378-F914F64C-8147-4C61-A76A-B3B0E9653DF0Q26750858-DEDACC6A-DF5C-4BB9-B822-AFC213A6ADA5Q26766647-3729E286-59D3-48C4-BC95-77D95042562DQ28068930-5C630223-CE03-4EB2-96E3-11F00F6FCB8DQ33912148-64C0A2E6-9597-4DD2-AAB2-D9A850023968Q35173399-1757B6A3-8CCB-4BDC-B593-80572719AE69Q35632327-F70171F6-9F84-4E04-9D92-BCE57E2DA178Q35697321-439D7C40-F8A2-441A-A0DB-8A2CDFECDDEDQ35700740-9F2E41BD-3A82-4832-9569-A01A2F19382DQ35975638-F3C64D1D-9D01-449D-8D22-E0E9E7EB5A85Q36301463-6F224A06-452A-45E3-AC56-FBBD31A011E8Q36375374-CE3FAA33-AC67-4097-8BBC-917C7574C955Q36414514-374C7DF5-8188-428E-80B0-3936B67CC039Q36464702-C8FC5880-2966-4C90-85D0-6E9CF448C25EQ37321149-9CAEBD25-E5EA-4CAC-B7B4-13A17E539390Q37688309-FDFDC603-2192-4FB9-9F42-1B64A33DF722Q37725406-CBCB8E6D-A832-48C0-9A51-38621383916CQ38372127-6F3D78A8-3B3C-41AB-9844-3713DBB7F963Q38632738-0613780E-4BC8-4D2F-AAC6-7C6ED15A23FBQ38706298-8087BDF9-8F3E-4902-980A-6826C2D596BEQ38909984-67D38668-1E8C-402D-BC97-B48A9763096BQ38953629-0A65D141-AECC-44E7-937D-0CCAE8C5E92AQ41615810-00C1B697-C4AB-44BF-A2CC-7F8849416D91Q41718006-8406B0CF-5D64-4135-843A-782F256EBE7FQ41883809-C051FEF8-53BD-4446-B3DA-AFE553AFBEADQ43760668-83543D57-3206-4466-8BC0-FB65CA498F9DQ47309064-AFDB1788-0D24-46F6-B0C5-E82ADA2009B0Q48089892-BDDE6D00-5337-4670-9C1B-F55163B5FABFQ49359901-BD8BA2FC-2C37-4C92-9307-D99037F65FC8Q50900131-C60D96A4-F235-4C3A-80C0-BEF8253BB9FDQ58050534-A6209CFD-497D-4357-B512-F9F3EF264137Q58050536-8C959C66-428D-4F70-82A9-9FD776A28F73
P2860
Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacogenetics of the DNA re ...... h platinum-based chemotherapy.
@ast
Pharmacogenetics of the DNA re ...... h platinum-based chemotherapy.
@en
type
label
Pharmacogenetics of the DNA re ...... h platinum-based chemotherapy.
@ast
Pharmacogenetics of the DNA re ...... h platinum-based chemotherapy.
@en
prefLabel
Pharmacogenetics of the DNA re ...... h platinum-based chemotherapy.
@ast
Pharmacogenetics of the DNA re ...... h platinum-based chemotherapy.
@en
P2093
P1433
P1476
Pharmacogenetics of the DNA re ...... h platinum-based chemotherapy.
@en
P2093
Agustí Barnadas
Cinta Pallarés
David Páez
Elisabeth Del Río
Ivana Sullivan
Juliana Salazar
Margarita Majem
Montserrat Baiget
P304
P356
10.1016/J.CANLET.2014.07.023
P407
P577
2014-07-25T00:00:00Z